Delivery Order SPE2DB24D2101-SPE2DB25FKKSV

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.96, is for the delivery of VAXELIS vaccine syringes (0.5 mL) and has a completion date of February 12, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the VAXELIS vaccine in 0.5 mL vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,906.26 and a period of performance through May 1, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.37, is for the procurement of the VAXELIS vaccine vial (0.5 mL). The contract has an ultimate completion date of February 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $1,918.44 firm fixed-price contract has a completion date of May 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This delivery order contract, valued at $1,239.24, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is for the provision of VAXELIS vaccine syringes (0.5 mL) to be delivered by January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This $3,586.26 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS Vaccine in 0.5mL vials, with a completion date of May 14, 2024. This contract award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $3,015.25 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,394.80, is for the delivery of VAXELIS vaccine syringes (0.5mL) and has an ultimate completion date of March 25, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed price contract is for the delivery of VAXELIS vaccine syringes, with a period of performance through February 10, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the VAXELIS vaccine syringe 0.5ML, with a ceiling value of $1,278.96 and a completion date of December 27, 2024. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a for-profit organization registered in...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKKSV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the VAXELIS vaccine in 0.5 mL vials. The $14,741.19 firm fixed-price contract has a completion date of May 22, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/20/25, 10:01 AM